119 related articles for article (PubMed ID: 19240363)
1. Muscular force is reduced in neurofibromatosis type 1.
Souza JF; Passos RL; Guedes AC; Rezende NA; Rodrigues LO
J Musculoskelet Neuronal Interact; 2009; 9(1):15-7. PubMed ID: 19240363
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of the muscular compartments and osseous strength in neurofibromatosis type 1 using peripheral quantitative computed tomography.
Stevenson DA; Moyer-Mileur LJ; Carey JC; Quick JL; Hoff CJ; Viskochil DH
J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):145-9. PubMed ID: 15951630
[TBL] [Abstract][Full Text] [Related]
3. Maximal isometric force and muscle cross-sectional area of the forearm in fencers.
Margonato V; Roi GS; Cerizza C; Galdabino GL
J Sports Sci; 1994 Dec; 12(6):567-72. PubMed ID: 7853453
[TBL] [Abstract][Full Text] [Related]
4. Muscle volume compared to cross-sectional area is more appropriate for evaluating muscle strength in young and elderly individuals.
Akagi R; Takai Y; Ohta M; Kanehisa H; Kawakami Y; Fukunaga T
Age Ageing; 2009 Sep; 38(5):564-9. PubMed ID: 19596739
[TBL] [Abstract][Full Text] [Related]
5. Muscle weakness in children with neurofibromatosis type 1.
Cornett KM; North KN; Rose KJ; Burns J
Dev Med Child Neurol; 2015 Aug; 57(8):733-6. PubMed ID: 25913846
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting maximal momentary grip strength.
Martin S; Neale G; Elia M
Hum Nutr Clin Nutr; 1985 Mar; 39(2):137-47. PubMed ID: 3926728
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D status and muscle function in children with neurofibromatosis type 1 (NF1).
Hockett CW; Eelloo J; Huson SM; Roberts SA; Berry JL; Chaloner C; Rawer R; Mughal MZ
J Musculoskelet Neuronal Interact; 2013 Mar; 13(1):111-9. PubMed ID: 23445921
[TBL] [Abstract][Full Text] [Related]
8. Peripheral muscle weakness in RASopathies.
Stevenson DA; Allen S; Tidyman WE; Carey JC; Viskochil DH; Stevens A; Hanson H; Sheng X; Thompson BA; Okumura MJ; Reinker K; Johnson B; Rauen KA
Muscle Nerve; 2012 Sep; 46(3):394-9. PubMed ID: 22907230
[TBL] [Abstract][Full Text] [Related]
9. Bite force and handgrip force in patients with molecular diagnosis of myotonic dystrophy.
Guimaraes AS; Carlsson GE; Marie SK
J Oral Rehabil; 2007 Mar; 34(3):195-200. PubMed ID: 17302947
[TBL] [Abstract][Full Text] [Related]
10. [Growth charts for the Spanish population with neurofibromatosis type 1].
Rafia S; García-Peña JJ; López-Pisón J; Aguirre-Rodríguez J; Ramos-Lizana J; García-Pérez A; Martínez-Granero MA; Sans A; Campistol J; Peña-Segura JL; Espino-Hernández M
Rev Neurol; 2004 Jun 1-15; 38(11):1009-12. PubMed ID: 15202075
[TBL] [Abstract][Full Text] [Related]
11. Seasonal variations in the relationship between mid-upper arm circumference and maximum voluntary contraction among Ethiopian farmers.
Lemma F; Shetty P
Eur J Clin Nutr; 2009 Apr; 63(4):513-20. PubMed ID: 18073780
[TBL] [Abstract][Full Text] [Related]
12. Restoration of voluntary muscle strength after 3 weeks of cast immobilization is suppressed in women compared with men.
Clark BC; Manini TM; Hoffman RL; Russ DW
Arch Phys Med Rehabil; 2009 Jan; 90(1):178-80. PubMed ID: 19154845
[TBL] [Abstract][Full Text] [Related]
13. Deterioration of muscle function after 21-day forearm immobilization.
Kitahara A; Hamaoka T; Murase N; Homma T; Kurosawa Y; Ueda C; Nagasawa T; Ichimura S; Motobe M; Yashiro K; Nakano S; Katsumura T
Med Sci Sports Exerc; 2003 Oct; 35(10):1697-702. PubMed ID: 14523307
[TBL] [Abstract][Full Text] [Related]
14. Postural control in children with and without neurofibromatosis type 1.
Johnson BA; MacWilliams BA; Stevenson DA
Hum Mov Sci; 2014 Apr; 34():157-63. PubMed ID: 24630611
[TBL] [Abstract][Full Text] [Related]
15. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
16. Respiratory muscular strength decrease in children with myelomeningocele.
Ronchi CF; Antunes LC; Fioretto JR
Spine (Phila Pa 1976); 2008 Feb; 33(3):E73-5. PubMed ID: 18303448
[TBL] [Abstract][Full Text] [Related]
17. Effect of maturation on the relationship between muscle size and force production.
Tonson A; Ratel S; Le Fur Y; Cozzone P; Bendahan D
Med Sci Sports Exerc; 2008 May; 40(5):918-25. PubMed ID: 18408605
[TBL] [Abstract][Full Text] [Related]
18. [Handgrip strength in children and teenagers aged from 6 to 18 years: reference values and relationship with size and body composition].
Marrodán Serrano MD; Romero Collazos JF; Moreno Romero S; Mesa Santurino MS; Cabañas Armesilla MD; Pacheco Del Cerro JL; González-Montero de Espinosa M
An Pediatr (Barc); 2009 Apr; 70(4):340-8. PubMed ID: 19268640
[TBL] [Abstract][Full Text] [Related]
19. Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children.
Coudé FX; Mignot C; Lyonnet S; Munnich A
Behav Genet; 2006 Sep; 36(5):660-4. PubMed ID: 16474913
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of skin viscoelasticity in type 1 neurofibromatosis patients.
Mimoun N; Razzouq N; Wolkenstein P; Moreno JC; Marty JP; Lantieri L; Astier A; Paul M
Skin Pharmacol Physiol; 2006; 19(1):22-7. PubMed ID: 16247246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
